| Kirishima T, Yoshinami N, Marui A, et al.
Histological complete response in a case of advanced gastric endocrine carcinoma treated by irinotecan plus cisplatin. [Journal Article]
Nippon Shokakibyo Gakkai Zasshi 2009 Nov; 106(11):1616-24.
Abstract | Full Citation | Find Related Articles |
| Keizman D, Maimon N, Ish-Shalom M, et al.
An animal model for chemotherapy-associated steatohepatitis and its prevention by the oral administration of fatty acid bile acid conjugate. [JOURNAL ARTICLE]
Cancer 2009 Nov 4.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Nishiyama M, Wada S
Docetaxel: its role in current and future treatments for advanced gastric cancer. [Journal Article]
Gastric Cancer 2009; 12(3):132-41.
Abstract | Full Citation |
| Martin RC, Joshi J, Robbins K, et al.
Transarterial Chemoembolization of Metastatic Colorectal Carcinoma with Drug-Eluting Beads, Irinotecan (DEBIRI): Multi-Institutional Registry. [Journal Article]
J Oncol 2009.:539795.
Abstract | Full Citation |
| Martin RC, Robbins K, Tomalty D, et al.
Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report. [JOURNAL ARTICLE]
World J Surg Oncol 2009 Nov 3; 7(1):80.
Abstract | Full Citation |
| Ling LU, Lin H, Tan KB, et al.
The role of protein kinase C in the synergistic interaction of safingol and irinotecan in colon cancer cells. [JOURNAL ARTICLE]
Int J Oncol 2009 Dec; 35(6):1463-1471.
Abstract | Full Citation |
| Fekrazad HM, Verschraegen CF, Royce M, et al.
A Phase I Study of Flavopiridol in Combination With Gemcitabine and Irinotecan in Patients With Metastatic Cancer. [JOURNAL ARTICLE]
Am J Clin Oncol 2009 Oct 30.
Abstract | Full Citation |
| Richman SD, Seymour MT, Chambers P, et al.
KRAS and BRAF Mutations in Advanced Colorectal Cancer Are Associated With Poor Prognosis but Do Not Preclude Benefit From Oxaliplatin or Irinotecan: Results From the MRC FOCUS Trial. [JOURNAL ARTICLE]
J Clin Oncol 2009 Nov 2.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Dexheimer TS, Gediya LK, Stephen AG, et al.
4-Pregnen-21-ol-3,20-dione-21-(4-bromobenzenesufonate) (NSC 88915) and Related Novel Steroid Derivatives as Tyrosyl-DNA Phosphodiesterase (Tdp1) Inhibitors. [JOURNAL ARTICLE]
J Med Chem 2009 Nov 2.
Abstract | Full Citation | Find Related Articles |
| Huh JW, Park YA, Lee KY, et al.
Heterogeneity of adenosine triphosphate-based chemotherapy response assay in colorectal cancer--secondary publication. [Journal Article]
Yonsei Med J 2009 Oct 31; 50(5):697-703.
Abstract | Full Citation |
  |
